Skip to main content
. 2017 Aug 8;12:2363–2371. doi: 10.2147/COPD.S138103

Table S1.

Association between presence of AL and medical history of 22 disease categories

Explanatory variable Unadjusted
Adjusteda
OR (95% CI) P-value OR (95% CI) P-value
Sex
 Female 0.38 (0.34–0.42) <0.0001 0.59 (0.52–0.67) <0.0001
 Male Reference Reference
Age (10-year age increase) 1.95 (1.87–2.03) <0.0001 1.99 (1.90–2.09) <0.0001
BMI (1 kg/m2 increase) 0.98 (0.97–0.99) 0.0006 0.96 (0.95–0.98) <0.0001
Smoking history (pack-years)
 0–14 Reference Reference
 15–24 1.81 (1.52–2.16) <0.0001 1.78 (1.46–2.17) <0.0001
 25–49 3.60 (3.20–4.06) <0.0001 2.60 (2.24–3.00) <0.0001
 ≥50 6.88 (6.04–7.84) <0.0001 3.69 (3.15–4.33) <0.0001
 Unknown 2.57 (1.75–3.77) <0.0001 1.92 (1.28–2.88) 0.0017
Medical history
 Pulmonary tuberculosis
  No Reference Reference
  Yes 2.82 (2.35–3.38) <0.0001 1.72 (1.39–2.11) <0.0001
 Malignant neoplasm
  No Reference Reference
  Yes 1.20 (1.10–1.32) <0.0001 0.91 (0.82–1.01) 0.0700
 Cancer of oropharynx and trachea
  No Reference Reference
  Yes 1.66 (1.32–2.09) <0.0001 1.08 (0.84–1.40) 0.5380
 Primary lung cancer
  No Reference Reference
  Yes 2.85 (2.47–3.28) <0.0001 1.50 (1.28–1.77) <0.0001
 Thyroid disease
  No Reference Reference
  Yes 0.69 (0.61–0.79) <0.0001 1.02 (0.88–1.18) 0.8025
 Diabetes mellitus
  No Reference Reference
  Yes 1.23 (1.13–1.35) <0.0001 0.91 (0.82–1.00) 0.0600
 Hyperlipidemia
  No Reference Reference
  Yes 1.53 (1.35–1.75) <0.0001 1.11 (0.96–1.29) 0.1446
 Major depressive disorder
  No Reference Reference
  Yes 0.91 (0.59–1.41) 0.6701 0.81 (0.51–1.29) 0.3754
 Essential hypertension
  No Reference Reference
  Yes 1.82 (1.63–2.05) <0.0001 1.1 (0.96–1.25) 0.1597
 Myocardial infarction
  No Reference Reference
  Yes 2.02 (1.70–2.40) <0.0001 1.22 (1.01–1.48) 0.0399
 Other heart diseases
  No Reference Reference
  Yes 2.04 (1.80–2.31) <0.0001 1.36 (1.18–1.56) <0.0001
 Arteriosclerosis
  No Reference Reference
  Yes 1.45 (1.23–1.70) <0.0001 1.08 (0.90–1.30) 0.3945
 Cerebrovascular disease
  No Reference Reference
  Yes 1.47 (1.26–1.70) <0.0001 0.94 (0.79–1.11) 0.4517
 Cerebral infraction and TIA
  No Reference Reference
  Yes 1.59 (1.35–1.87) <0.0001 0.96 (0.80–1.15) 0.6542
 Arterial thrombosis
  No Reference Reference
  Yes 1.54 (1.35–1.76) <0.0001 1.12 (0.97–1.30) 0.1291
 Acute bronchitis
  No Reference Reference
  Yes 1.21 (0.89–1.65) 0.2187 1.1 (0.76–1.55) 0.5769
 Pneumonia
  No Reference Reference
  Yes 1.64 (1.40–1.90) <0.0001 1.15 (0.96–1.37) 0.1254
 Liver disease
  No Reference Reference
  Yes 1.22 (1.09–1.36) 0.0003 0.98 (0.87–1.10) 0.7210
 Rheumatoid arthritis
  No Reference Reference
  Yes 0.84 (0.69–1.02) 0.0863 0.94 (0.76–1.17) 0.6052
 Gout
  No Reference Reference
  Yes 1.57 (1.02–2.41) 0.0392 1.04 (0.63–1.71) 0.8830
 Osteoporosis
  No Reference Reference
  Yes 0.93 (0.73–1.19) 0.5628 0.97 (0.74–1.26) 0.8073
 Kidney disease
  No Reference Reference
  Yes 1.25 (1.11–1.40) 0.0001 1.01 (0.89–1.14) 0.9361

Note:

a

Model was adjusted for age, sex, BMI and smoking history.

Abbreviations: AL, airflow limitation; OR, odds ratio; CI, confidence interval; BMI, body mass index; TIA, transient cerebral ischemic attack.